Join to View Full Profile
75 Francis StBoston, MA 02115
Phone+1 617-732-5500
Fax+1 401-793-7801
Dr. Kelly is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Colleen Kelly is a gastroenterologist in Providence, RI and is affiliated with Miriam Hospital. She received her medical degree from The Ohio State University College of Medicine and has been in practice 18 years. She is experienced in general gastroenterology and inflammatory bowel disease.
Education & Training
Rhode Island Hospital/Brown University HealthFellowship, Gastroenterology, 2003 - 2006
Boston University Medical CenterResidency, Internal Medicine, 1999 - 2002
Ohio State University College of MedicineClass of 1999
Certifications & Licensure
MA State Medical License 2001 - 2028
MO State Medical License 2025 - 2027
RI State Medical License 2005 - 2026
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2013, 2015, 2017
- CMS Meaningful Use Stage 2 Certification Cloverleaf Integration Suite, Infor (US), Inc., 2013, 2015, 2017
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2013, 2015, 2017
Clinical Trials
- Fecal Transplant for Relapsing C. Difficile Infection Start of enrollment: 2012 Oct 01
- Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection Start of enrollment: 2015 Mar 01
- SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01
Publications & Presentations
PubMed
- The Management of Fulminant C. difficile Infection in an Immunocompromised Patient: Balancing Risk and Necessity.Colleen R Kelly, Elizabeth Hohmann, Matthew D Jankowich, David Stewart, Monika Fischer
Gastroenterology. 2026-07-07 - 1 citationsMirikizumab Long-Term Efficacy and Safety in Patients With Crohn's Disease: Results From the VIVID-2 Open-Label Extension Trial.Bruce E Sands, Edward L Barnes, Geert D'Haens, Tadakazu Hisamatsu, Miguel Regueiro
Clinical Gastroenterology and Hepatology. 2026-03-05 - Diagnosis and Management of Clostridioides difficile.Colleen R Kelly, Paul Feuerstadt
The American Journal of Gastroenterology. 2026-03-01
Press Mentions
Approach to Weight Management in GI PracticeNovember 10th, 2025- Easy Access to Conventional FMT Continues — for NowDecember 16th, 2024
- ‘See C. Diff Diagnosed’ Campaign Aims to Spread Awareness, Defuse Public Health ThreatNovember 26th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
